Business Description
PT Phapros Tbk
ISIN : ID1000147507
Total Employee Number:
1,262Compare
Compare
Traded in other countries / regions
PEHA.Indonesia IPO Date
2018-12-26Description
PT Phapros Tbk is a pharmaceutical company in Indonesia. The company is engaged in the industrial/manufacturing sector by producing and/or trading medicines, health instruments, chemical goods, and other similar goods in import, export, and other kinds of industry. The company operates through Over Counter (OTC), Ethical, Generic Drugs Bearing (OGB), and Toll Manufacturing segments. It derives maximum revenue from OGB segment.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.19 | |||||
Equity-to-Asset | 0.29 | |||||
Debt-to-Equity | 1.72 | |||||
Debt-to-EBITDA | 6.02 | |||||
Interest Coverage | 2 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 0.99 | |||||
Beneish M-Score | -3.08 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -7 | |||||
3-Year EBITDA Growth Rate | -2.6 | |||||
3-Year EPS without NRI Growth Rate | 0.8 | |||||
3-Year FCF Growth Rate | -9.5 | |||||
3-Year Book Growth Rate | -18 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 62.91 | |||||
9-Day RSI | 53.17 | |||||
14-Day RSI | 49.19 | |||||
3-1 Month Momentum % | -23.87 | |||||
6-1 Month Momentum % | -21.85 | |||||
12-1 Month Momentum % | -28.05 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.1 | |||||
Quick Ratio | 1.65 | |||||
Cash Ratio | 0.43 | |||||
Days Inventory | 131.09 | |||||
Days Sales Outstanding | 150.38 | |||||
Days Payable | 58.78 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.99 | |||||
Forward Dividend Yield % | 1.99 | |||||
5-Year Yield-on-Cost % | 2 | |||||
Shareholder Yield % | 18.43 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 52.77 | |||||
Operating Margin % | 9.71 | |||||
Net Margin % | 3.67 | |||||
EBITDA Margin % | 12.39 | |||||
FCF Margin % | 18.21 | |||||
OCF Margin % | 18.97 | |||||
ROE % | 8.93 | |||||
ROA % | 2.45 | |||||
ROIC % | 4.6 | |||||
3-Year ROIIC % | 2.67 | |||||
ROC (Joel Greenblatt) % | 11.95 | |||||
ROCE % | 10.29 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 6.05 | |||||
PE Ratio without NRI | 6.38 | |||||
Shiller PE Ratio | 12.96 | |||||
Price-to-Owner-Earnings | 4.94 | |||||
PS Ratio | 0.22 | |||||
PB Ratio | 0.5 | |||||
Price-to-Tangible-Book | 0.59 | |||||
Price-to-Free-Cash-Flow | 1.21 | |||||
Price-to-Operating-Cash-Flow | 1.17 | |||||
EV-to-EBIT | 7.89 | |||||
EV-to-EBITDA | 6.79 | |||||
EV-to-Revenue | 0.84 | |||||
EV-to-FCF | 4.55 | |||||
Price-to-GF-Value | 0.66 | |||||
Price-to-Projected-FCF | 0.13 | |||||
Price-to-Graham-Number | 0.41 | |||||
Earnings Yield (Greenblatt) % | 12.68 | |||||
FCF Yield % | 82.72 | |||||
Forward Rate of Return (Yacktman) % | 31.35 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
PT Phapros Tbk Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil Rp) | 961,296.967 | ||
| EPS (TTM) (Rp) | 41.681 | ||
| Beta | 0.7515 | ||
| 3-Year Sharpe Ratio | -1 | ||
| 3-Year Sortino Ratio | -1.15 | ||
| Volatility % | 26.74 | ||
| 14-Day RSI | 49.19 | ||
| 14-Day ATR (Rp) | 21.373213 | ||
| 20-Day SMA (Rp) | 250.7 | ||
| 12-1 Month Momentum % | -28.05 | ||
| 52-Week Range (Rp) | 206 - 460 | ||
| Shares Outstanding (Mil) | 840 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
PT Phapros Tbk Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
PT Phapros Tbk Stock Events
| Event | Date | Price (Rp) | ||
|---|---|---|---|---|
| IDR 5.010000 Cash Dividend | 2026-06-23 | 266.00 (+2.31%) |
Show
Entries
PT Phapros Tbk Frequently Asked Questions
What is PT Phapros Tbk(ISX:PEHA)'s stock price today?
The current price of ISX:PEHA is Rp252.00. The 52 week high of ISX:PEHA is Rp460.00 and 52 week low is Rp206.00.
When is next earnings date of PT Phapros Tbk(ISX:PEHA)?
The next earnings date of PT Phapros Tbk(ISX:PEHA) is .
Does PT Phapros Tbk(ISX:PEHA) pay dividends? If so, how much?
The Dividend Yield %  of PT Phapros Tbk(ISX:PEHA) is 1.99% (As of Today), Highest Dividend Payout Ratio of PT Phapros Tbk(ISX:PEHA) was 2.4. The lowest was 0.26. And the median was 1.45. The  Forward Dividend Yield % of PT Phapros Tbk(ISX:PEHA) is 1.99%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | ||
|---|---|---|---|
| Indonesia's Legacy in the Global Vaccine Landscape: Bio Farma and DCVMN Strengthen Health Resilience through Global Partnership | 2025-10-21 |
Articles on PT Phapros Tbk
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers